SYSBIOGEN R&D
Technology
SYSBIOGEN aims to apply machine learning-based cancer diagnosis technology and BDA (Blocker Displacement Amplification) application technology to early diagnosis and companion diagnosis of cancer.
Read more
R&D Pipeline
SYSBIOGEN is developing an early diagnosis system for prostate cancer and breast cancer, and a system for monitoring minimal residual disease in blood cancer.
Read more
About SYSBIOGEN
-
Greetings
Biotechnology company that seeks
the realization of P4 precision medicine.Read more
-
Locations
Directions to SYSBIOGEN
Read more